Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...
EU health regulator clears use of AI tool in fatty liver disease trials
A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH ...
Yahoo Finance9d
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic ...
Morningstar3d
Madrigal Pharmaceuticals Inc MDGL
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Nasdaq9d
Madrigal Pharmaceuticals Announces Dr. Fred Craves' Retirement and Appointment of Dr. Jacqualyn Fouse to Board of Directors
Madrigal Pharmaceuticals, Inc. announced the appointment of Jacqualyn Fouse, Ph.D. to its Board of Directors, replacing Fred Craves, Ph.D., who will retire in July 2025. Julian Baker, Chairman of ...
Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA
BofA raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $239 from $154 and keeps an Underperform rating on the shares. The Q4 ...
Oppenheimer Asset Management Inc. Decreases Stock Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
Oppenheimer Asset Management Inc. decreased its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by ...
Principal Financial Group Inc. Sells 96 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
Principal Financial Group Inc. cut its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by ...